Metrics as of 10/13/2026, 06:37 PM (Berlin time), refresh in progress.
Auxly Cannabis Group Inc.
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis…
1D
+0.6%
1W
+1.5%
1M
+0.6%
6M
+67.0%
YTD
+67.0%
1Y
+73.0%
2Y
+505.4%
5Y
+13.8%
10Y
–
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~31% stronger price swings than usual
0
STRONG BUY
0
BUY
1
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Hold
As of: 28/11/2022
P/E
10.18
P/B
1.87
EV/EBITDA
9.83
RETURN ON EQUITY
4.1%
NET MARGIN
16.8%
DEBT/EQUITY
0.29
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
76.5%
FLOAT SHARES
77,511,917
AVG. DAILY VOLUME (30D)
131,427
Auxly Cannabis Group Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Hugo Alves, the company employs around 446 people.
The IPO was on 08/06/2018; the stock trades on TSX under the ticker XLY.TO.
1 analysts rate the stock, the consensus is Hold (as of 28/11/2022).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 31% stronger than usual.
No, Auxly Cannabis Group currently does not pay a dividend.
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Auxly Cannabis Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.